title: DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis.
abstract: BACKGROUND
  Leucoencephalopathy with brain stem and spinal cord involvement and high brain lactate (LBSL) was first defined by characteristic magnetic resonance imaging and spectroscopic findings. The clinical features include childhood or juvenile onset slowly progressive ataxia, spasticity, and dorsal column dysfunction, occasionally accompanied by learning difficulties. Mutations in DARS2, encoding mitochondrial aspartyl-tRNA synthetase, were recently shown to cause LBSL. The signs and symptoms show some overlap with the most common leucoencephalopathy of young adults, multiple sclerosis (MS).
  
  
  OBJECTIVE
  To clarify the molecular background of LBSL patients in Finland, and to look for DARS2 mutations in a group of MS patients.
  
  
  METHODS
  Clinical evaluation of LBSL patients, DARS2 sequencing and haplotype analysis, and carrier frequency determination in Finland.
  
  
  RESULTS
  All eight LBSL patients were compound heterozygotes for DARS2 mutations: all carried R76SfsX5 change, seven had M134_K165del, and one had C152F change. Axonal neuropathy was found in five of the eight patients. The carrier frequencies of the R76SfsX5 and M134_K165del mutations were 1:95 and 1:380, respectively. All patients shared common European haplotypes, suggestive of common European LBSL ancestors. No enrichment of the two common DARS2 mutations was found in 321 MS patients.
  
  
  CONCLUSIONS
  All LBSL patients were compound heterozygotes, which suggests that DARS2 mutation homozygosity may be lethal or manifest as a different phenotype. The authors show here that despite identical mutations the clinical picture was quite variable in the patients. Axonal neuropathy was an important feature of LBSL. DARS2 mutations cause childhood-to-adolescence onset leucoencephalopathy, but they do not seem to be associated with MS.
authors: Research Programme of Molecular Neurology,Biomedicum-Helsinki, University of Helsinki, Helsinki, Finland. pirjo.isohanni@helsinki.fi
authors: P
authors: P
authors: Isohanni
authors: T
authors: T
authors: Linnankivi
authors: J
authors: J
authors: Buzkova
authors: T
authors: T
authors: Lönnqvist
authors: H
authors: H
authors: Pihko
authors: L
authors: L
authors: Valanne
authors: P J
authors: PJ
authors: Tienari
authors: I
authors: I
authors: Elovaara
authors: T
authors: T
authors: Pirttilä
authors: M
authors: M
authors: Reunanen
authors: K
authors: K
authors: Koivisto
authors: S
authors: S
authors: Marjavaara
authors: A
authors: A
authors: Suomalainen
mesh_terms: D000328:Adult; D001226:Aspartate-tRNA Ligase / Q000235:genetics*; D005260:Female; D005387:Finland; D006239:Haplotypes; D006801:Humans; D056784:Leukoencephalopathies / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D008928:Mitochondria / Q000235:genetics; D028361:Mitochondrial Diseases / Q000235:genetics*; D009103:Multiple Sclerosis / Q000235:genetics*
chemical_list: D001226:Aspartate-tRNA Ligase